Track the 泰恩康 stock price and the full insider trade history of the company, a listed equity based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 泰恩康 has logged 13 public disclosures. Market capitalisation: €8.5bn. The latest transaction was reported on 6 June 2024 (Purchase). Among the most active insiders: 李挺. All data is accessible without an account.
13
Insider Decl.
n/a
Thresholds
€2m
13 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
Buys €2mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 20,476 of 28,857 companies
37.7
score / 100
Value
33
Quality
42
FCF yld-1.4%
Earn yld0.3%
EV/EBITDA·
ROE0.4%
Gross mgn54%
Net mgn4.2%
Debt/EBITDA5.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
泰恩康 is a company operating in the health and pharmaceutical sector, listed on the XSHE market. It specializes in the development and marketing of pharmaceutical products.